Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Hepatocellular × avelumab × Clear all

Phase

Status

Terminated 2 Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Neoplasms 9 Carcinoma, Transitional Cell 7 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Urinary Bladder Neoplasms 5 Ovarian Neoplasms 5 Carcinoma, Renal Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Glioblastoma 3 Carcinoma, Neuroendocrine 3 Stomach Neoplasms 2 Neuroendocrine Tumors 2 Kidney Neoplasms 2 Kidney Diseases 2 Glioma 2 Fallopian Tube Neoplasms 2 Carcinoma, Merkel Cell 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Testicular Diseases 1 Sezary Syndrome 1 Sarcoma 1 Rectal Neoplasms 1

Interventions

Sorafenib 109 Nivolumab 31 pembrolizumab 25 lenvatinib 25 Bevacizumab 24 Doxorubicin 21 Radiosurgery 18 Oxaliplatin 18 Radiofrequency Ablation 17 Hepatectomy 16 Capecitabine 14 Magnetic Resonance Spectroscopy 13 Fluorouracil 13 Cisplatin 12 atezolizumab 11 Leucovorin 11 Gemcitabine 10 Ipilimumab 9 Erlotinib Hydrochloride 9 tislelizumab 8 cabozantinib 8 Sirolimus 8 Irinotecan 8 Ramucirumab 7 Embolization, Therapeutic 7 gadolinium ethoxybenzyl DTPA 6 Radiotherapy 6 Pharmaceutical Preparations 6 Mitomycin 6 Liver Transplantation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03389126 2021-03-17

AvelumabHCC

Seoul National University Hospital

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡